Gentamicin is an aminoglycoside antibiotic effective against aerobic gram-negative bacteria and is also used in veterinary medicine, particularly in the swine and bovine industries. However, no gentamicin product is currently approved for treating equine diseases in Korea. The present study aims to examine the time-dependent residue of gentamicin in horses after intravenous injection (IV) via jugular vein. The test product was injected at 6.6 mg/kg BW via jugular vein in nine horses. Blood was collected from the horse's jugular vein at 15 minutes, 30 minutes, 1, 4, 8, 12, 24 and 48 hours after injection. To purify the gentamicin in serum, 100μL of 20 mM HFBA in DW, 100 μL of 30% trichloroacetic acid and 300 μL of 20 mM heptafluorobutyric acid (HFBA) in acetonitrile (ACN) were added to 500 μL of serum and supernatant was applied to LC-MS/MS after centrifugation. LC-MS/MS-8050 analyzed the level of gentamicin in serum with Electrospray ionization (ESI) and multiple reaction monitoring (MRM) positive mode. Gentamicin C1 was 478 m/z and product ions were 322, 157 m/z. Precursor ion of Gentamicin C1a was 450 m/z and product ions were 322, 160 m/z. Precursor ion of Gentamicin C2 and C2a was 464 m/z and product ions were 322, 160 m/z. The LC column was a C18 and mobile phase composed of 20 mM HFBA in 5% ACN and 20 mM HFBA in 50% ACN. The amount of gentamicin was calculated by adding four components of gentamicin (C1, C1a, C2 and C2a). The pharmacokinetic parameters of gentamicin were calculated by the WinNonlin program. The Cmax of gentamicin in horse serum was 93 ± 17 μg/kg and the Tmax was 0.25 ± 0 hours. The T1/2 was 6.41 ± 2.32 hours and the CLt was 0.05 ± 0.01L/hr/kg. The Vd was shown as 0.44 ± 0.13 L/kg and the MRT was 1.98 ± 0.55 hours. In conclusion, our data provides useful pharmacokinetic parameters for gentamicin in horses following IV injection.

국내 수박(Citrullus lanatus) 품종의 발아율에 대한 Solid Matrix Priming(SMP)의 영향을 평가하였다. Micro cel-E가 SMP 처리에 가장 이상적인 matrix로 밝혀졌으며, 종자:matix:물의 비율은 10:5:10(w/w/w)로, 25°C 에서 3일 동안 처리했을 때 유근의 돌출없이 발아속도가 촉진되었다. SMP 처리 과정 동안 초기 4시간 동안의 수분 흡수율은 급격하게 증가했으며, 이후 72시간 동안은 더 느린 속도로 흡수되었고, 처리 마지막 시간까지 수분 흡수 율은 41%이었다. 발아 온도와 상관없이, SMP 처리된 종자는 발아 시간이 단축되면서 발아율이 향상되었다. 특히, 최적 발아 온도보다 낮은 온도에서 발아율이 높았다. 품종별 차이는 있었으나, 특히 ‘해찬꿀’과 ‘리코스위트’ 품종 에서 발아율이 유의미하게 증가하였다. 또한 일부 품종에서 SMP 처리 종자의 유묘출현율과 초장, 생체중이 무처 리에 비하여 증가한 값을 보였으며, SMP 처리로 종자의 발아속도 및 유묘활력을 증진시켜 우량 묘 확보가 가능한 것으로 판단되었다.

본 연구에서는 국내에서 판매되는 24개 건어포 및 조미 건어포 제품의 종 판별 및 표시사항 준수 여부를 평가했 다. 이러한 수산가공품에 사용된 원재료의 종판별을 위해 cytochrome c oxidase subunit I 및 cytochrome b 유전자 의 염기서열을 분석하여 NCBI GenBank 및 BOLD 데이 터베이스에 등록되어 있는 생물종의 염기서열과 비교 후 계통 분석을 수행했다. 분석 결과 13개 종(Hyporhamphus quoyi, Gadus chalcogrammus, Lophius litulon, Conger myriaster, Paramonacanthus pusillus, Hyporhamphus sajori, Gadus macrocephalus, Hoplobrotula armata, Callionymus meridionalis, Liparis tanakae, Dosidicus gigas, Lagocephalus cheesemanii, and Takifugu vermicularis)이 확인되었다. 일반 명(장어, 오징어 등)을 포함할 경우 16개 제품(66.7%)에서 표시사항과 판별된 종 간에 불일치가 확인되었으며, 일반 명을 제외할 경우 불일치 비율은 41.7%로 감소했다. 식품 유형별로는 조미건어포 제품(n=20, 70%)에서 건어포 제품 (n=4, 50%) 보다 높은 비율의 불일치 비율이 관찰되었다. 원산지별 분석 결과 특정 국가와 불일치 비율과의 상관성 은 확인할 수 없었다. 이러한 연구 결과는 건포류 제품의 주기적 모니터링 수행 및 수산물의 국명 표시 선을 위한 기초자료로 쓰일 수 있을 것이다.

Moringa oleifera, a versatile plant, has been traditionally used to treat various ailments and is gaining scientific attention due to its potential as a medicine. Native to the Indian subcontinent, it is widely grown in tropical and subtropical regions, thriving in Asia, Africa, and South America, especially in arid climates. This study explores the antioxidant potential of Moringa oleifera leaf extract (MOLE), employing a comprehensive screening approach with various solvents to identify the most effective extraction method. Initial experiments assessed antioxidant efficacy and yield using distilled water (D.W.), 95% ethanol, and 95% methanol. Among these, 95% ethanol extract demonstrated superior antioxidant activity, confirmed through assays such as 2,2-diphenyl-1-14 picrylhydrazyl (DPPH) radical scavenging assay, total polyphenol content analysis, and reducing power assay. In addition, with the 95% ethanol MOLE, a higher extraction efficiency was yielded compared to other solvents, making it the most effective for large-scale preparation. HPLC analysis revealed the presence of key bioactive compounds, including ellagic acid, rutin, Q-3-O, quercetin, and kaempferol. Results revealed that MOLE, prepared using 95% ethanol, exhibited remarkable antioxidant properties, attributed to its rich polyphenolic content. This research underscores the therapeutic potential of MOLE as a natural antioxidant source and highlights the importance of solvent optimization in phytochemical extractions.

In this study, an simultaneous LC-MS/MS multi-residue analytical method was developed and validated for the residues of six neonicotinoid insecticides (acetamiprid, clothianidin, dinotefuran, imidacloprid, thiacloprid, and thiamethoxam) in honey. Sample preparation included a combination of QuEChERS extraction kit and liquid-liquid extraction method to effectively extract pesticide components from the honey matrix and optimized analytical conditions to achieve high sensitivity and selectivity. The limits of detection (LOD) and the limits of quantitation (LOQ) were set in the range of 6-15 ng/mL and 19-44 ng/mL, respectively and the correlation coefficient (R²) was greater than 0.99, confirming good linearity. In addition, the intra-day recoveries for each pesticide were 75-104%, and the coefficient of variation (CV) was less than 20%, which met the guideline recommended by the Ministry of Food and Drug Safety. The LC-MS/MS method developed in this study is expected to be used as a multi-residue analysis method for 6 neonicotinoid pesticides in honey.

Clove (Syzygium aromaticum) is a highly valued medicinal plant native to Aisa. Widely used as a spice, renowned for its medicinal properties, particularly in Ayurveda and traditional Chinese medicine. In this study, clove bud extract (CBE) was prepared at different ethanol concentrations of 50%, 80%, and 90%, respectively. The antioxidant activity of the CBE was evaluated through DPPH, polyphenol, and reducing power assays, revealing its strong antioxidant potential, with 90% ethanol being the most effective extract. HPLC analysis identified eugenol (8.7 mg/g) as the major active compound, known to possess anti-inflammatory and antioxidant properties. Given the role of oxidative stress and inflammation in atopic dermatitis (AD), the therapeutic potential of CBE was explored using a 1-chloro-2, 4-dinitrobenzene (DNCB)-induced AD mouse model. Five-week-old BALB/c mice were induced with AD by topical application of DNCB. CBE was administered topically to the affected skin (back and ear) areas for 4 weeks. The treatment of CBE significantly reduced the severity of clinical dermatitis, decreased epidermal thickness, and lowered mast cell and eosinophil infiltration in skin tissue, as observed through hematoxylin eosin staining and toluidine blue staining. The results demonstrated CBE as a promising therapeutic agent for managing AD through its regulation of skin inflammation and oxidative stress, making it a potential candidate for future treatments of inflammatory skin disorders.

Background: Cisplatin, a chemotherapeutic agent often causes nephrotoxic side effects. Lipopolysaccharide (LPS) is known to induce pro-inflammatory responses, often leading to septic renal injury. We hypothesized that the combination of cisplatin and LPS would amplify renal injury, thereby improving a renal injury model. Therefore, we administered both agents to mice and evaluated renal injury indicators. Methods: Eight-week-old male C57BL/6 mice were injected with cisplatin (8, 10, or 12 mg/kg) and LPS (5 mg/kg) on days 1 and 4 following of each week. Mice were euthanized at specific time points to assess renal injury. Body weight, renal weight, area, and BUN levels were measured to evaluate renal damage. Additionally, hematoxylin and eosin (H&E) and Masson’s trichrome (MT) staining were performed to assess histological changes. Results: The combination of cisplatin and LPS significantly reduced body and renal weight compared to cisplatin alone. A high dose of cisplatin (12 mg/kg) resulted in a 50% mortality, while, lower doses (8 and 10 mg/kg) showed 100% survival. Significant renal injury was observed in the 10 mg/kg cisplatin group administered for two weeks. In the 8 mg/kg cisplatin group, no changes were observed after two weeks, but renal damage appeared after four weeks. Histological evaluations in the 10 mg/kg cisplatin group administered for two weeks showed renal injury features, including tubular damage and fibrosis. Conclusions: Administering cisplatin (10 mg/kg) with LPS for two weeks or cisplatin (8 mg/kg) with LPS for four weeks resulted in a distinct renal injury, effectively establishing a renal injury mouse model.

Following the previous study, which investigated the pharmacological properties of the Technekitty injection (Tc-99m), the toxicity of a single intravenous administration of the Technekitty injection (Tc-99m) and the side effects that may occur at the diagnostic dose were confirmed. The Technekitty injection (Tc-99m) was administered intravenously once at a dose of 0, 0.67, 2.0, and 6.0 mCi/kg to 5 male and female rats per group. Mortality, general symptom observation, and weight measurement were performed for 2 weeks, followed by observation of autopsy findings. There were no deaths, and no statistically significant weight change was observed. No abnormal systemic signs related to the Technekitty injection (Tc-99m) were observed. These results confirmed that Technekitty injection (Tc-99m) can be safely administered intravenously at doses up to 6.0 mCi/kg. Additionally, technetium-99m at an average dose of 2 mCi (74 MBq) has been verified as a diagnostic dose without adverse effects, allowing the Technekitty injection (Tc-99m) to be used safely without side effects at this dosage. This study demonstrates that the Technekitty injection (Tc-99m) has a wide safety margin, supporting its potential for clinical application. Moreover, these findings align with the nonclinical safety standards for radiopharmaceuticals, reinforcing its utility in veterinary medicine. The Technekitty injection (Tc-99m) is expected to be applicable for clinical diagnosis as a veterinary drug in Korea.

Thyroid scanning using technetium-99m (99mTc) is the gold standard for diagnosing feline hyperthyroidism. In cats with an overactive thyroid, a thyroid scan is the most appropriate imaging technique to detect and localize any hyperfunctional adenomatous thyroid tissue. In this study, the pharmacological properties of the Technekitty injection (Tc-99m), developed as a diagnostic agent for feline hyperthyroidism using 99mTc as an active ingredient, were tested in FRTL-5 thyroid follicular cell line and ICR mice. The percentage of cell uptake of the Tc-99m in FRTL-5 thyroid cells was 0.182 ± 0.018%, which was about 6 times higher compared to Clone 9 hepatocytes. This uptake decreased by 38.2% due to competitive inhibition by iodine (sodium iodide). In tissue distribution tests by using ICR mice, the highest distribution was observed in the liver, kidneys, spleen, lungs, and femur at 0.083 hours after administration, and this distribution decreased as the compound was excreted through the kidneys, the primary excretory organ. Maximum distribution was confirmed at 1 hour in the small intestine, 6 hours in the large intestine, and 2 hours in the thyroid gland. Additionally, the total amount excreted through urine and feces over 48 hours (2 days) was 78.80% of the injected dose, with 37.70% (47.84% of the total excretion) excreted through urine and 41.10% (52.16% of the total excretion) through feces. In conclusion, the Tc-99m has the same mechanism of action, potency, absorption, distribution, metabolism, and excretion characteristics as 99mTc used for feline hyperthyroidism in the United States, Europe, and other countries, because the Technekitty injection (Tc-99m) contains 99mTc as its sole active ingredient. Based on these results, the Technekitty injection (Tc-99m) is expected to be safely used in the clinical diagnosis of feline hyperthyroidism.

Afghanistan is a producer of high-quality pistachios among the top ten producers in the World. Nowadays, these edible nuts are losing their quality and quantity due to hemipteran insect infestation and their diversity during all growth phases in the country borderline. The expansion of the pistachio pest in Iran has caused concerns for Afghanistan, especially in the provinces of Herat, Badghis, and Takhar which are close to the Iran borders. Hence, this survey was initiated to primarily detect the phytophagous insect pest presence in the pistachio open forest areas and to know what management tools were effectively used in alleviation of the pest infestation. Our findings indicated that galling aphids, aphids, thrips, and root beetles received the maximum positive responses in the Herat province, but psyllids, aphids, root beetles, leave miners, fruit borers and thrips received the highest responses in Badghis province. In addition, Takhar province depicted plant bugs, twig borer moths, galling aphids, leaf miners, and leafhoppers got the most positive responses accordingly. In the meantime, the data showed that management outcomes were not satisfactory despite the use of sanitation, cultural practices, and chemical application. The survey presented significant differences in the prevalence of pest and in the application of pest control methods among the survey regions. Finally, it is essential to develop the strategy of integrated pest management in order to stop the phytophagous insects from turning into actual pests. This will reduce the pistachio loss annually and improve the nut culture quality in Afghanistan.

Background: Hanwoo cattle farmers aim to improve calf production and reproductive efficiency. Recovery of the reproductive tract postpartum is a critical factor influencing the postpartum period and conception of breeding cows. This study aimed to precisely analyze the recovery process of the reproductive tract in primiparous Hanwoo postpartum and to establish recovery criteria. Methods: Ten primiparous Hanwoo cows were used in this study. After parturition, estrus was examined daily using visual observations and estrus detection patches. Ovarian recovery, cervical diameter, and uterine horn diameter were examined using ultrasonography four times per week. Results: The analysis revealed that the first estrus occurred at 19.1 ± 6.5 days postpartum, the first ovulation at 27.1 ± 4.5 days, and the first normal estrus cycle at 39.2 ± 6.4 days. The ovulation rate during the first estrus was 40%. A normal estrus cycle occurred in 11.1% of patients at the first ovulation. The cervix diameter recovered to 42.0 ± 3.5 mm and the uterine horn diameter to 34.4 ± 7.1 mm by 24 days postpartum, with the difference in uterine horn diameter recovering to 2.6 ± 1.2 mm by 31 days postpartum. Conclusions: This study can aid in determining the optimal breeding time for postpartum primiparous Hanwoo cow and provide foundational data for Hanwoo breeding studies.

The purpose of this review is to provide a comprehensive analysis of the intricate relationships between cognitive control, depression, and emotion regulation. Cognitive control, encompassing processes such as attentional control, inhibitory control, and cognitive flexibility, plays a central role in regulating thoughts, behaviors, and emotions in alignment with internal goals and external demands. Depression, characterized by persistent feelings of sadness, hopelessness, and cognitive impairments, is associated with deficits in cognitive control processes. Emotion regulation strategies, such as cognitive reappraisal and expressive suppression, enable individuals to modulate emotional experiences and responses. The bidirectional relationships between cognitive control, depression, and emotion regulation underscore the complexity of cognitive and emotional processes in depression. Understanding these relationships is crucial for developing targeted interventions aimed at promoting cognitive and emotional well-being and preventing depression onset and recurrence. Moreover, recognizing the roles of cognitive control and emotion regulation in depression holds promise for informing clinical practice and enhancing therapeutic interventions. This review highlights the importance of considering cognitive control and emotion regulation in the assessment and treatment of depression and provides insights for future research and clinical practice.

대한민국의 해양레저산업은 세일링을 비롯한 다양한 형태의 수상레저 활동이 증가하는 추세에 따라 세계적으로 신흥시장으로 주목받고 있어 세일링 요트에 대한 수요가 높아질 것으로 추정된다. 이에 따라 2022년 현재 우리나라 요트 문화의 부흥과 보급을 위해 해 양수산부의 지원을 받아 28피트 세일 요트의 설계 및 개발이 착수되었다. 개발 초기 단계에서의 성능을 확인하고 이를 통해 설계 인자를 결정하기 위하여 속도 예측 프로그램 VPP(Velocity Prediction Program) 분석이 수행되었다. 본 연구에서 사용된 소프트웨어는 University of Southampton의 Wolfson Unit社의 WinDesign으로, 속도 예측에 적용된 유체역학적 데이터 모델은 Wolfson Unit社자체적인 조선공학 및 요트 연구 분야에서 수십 년간의 예인 수조 시험 데이터를 회귀 분석한 방법으로 대부분의 현대식 요트에 대해 신뢰할 수 있는 추정치를 제공 하는 것으로 여겨진다. 하지만 예인 수조 시험이나 CFD 수치해석 등을 통한 실험 결과적인 유체역학적 정보가 없기 때문에 소프트웨어에 서 제공하는 유체역학적 데이터 회귀 모델의 저항 값은 다소 차이가 있을 것으로 예상된다. 또한, 아직 미완료된 무게 중심 추정에 의한 VCG 값은 속도 예측의 입력 변수 중 하나로, 성능 결과에 어느 정도 영향을 미칠 수 있을 것으로 예상된다. 개발 세일 요트에 대한 최적 화된 보트 속도는 풍속 4, 8, 12, 16 및 20노트의 집세일 조합(최대 120° TWA) 및 스피네커 세일 조합(80° TWA부터) 모두에서 확인되었으 며, VPP를 활용하여 얻어진 최적화된 속도는 국제적으로 유사한 등급의 요트와 견줄수 있는 수준으로 확인되었다.

Background: Platelet-derived growth factor receptor alpha (PDGFRα) is essential for various biological processes, including fetal Leydig cell differentiation. The PDGFRαEGFP mouse model, which expresses an eGFP fusion gene under the native Pdgfrα promoter, serves as a valuable resource for exploring PDGFRα’s expression and function in vivo. This study investigates PDGFRα expression in adult testicular cells using PDGFRαEGFP mouse model. Methods: Genotyping PCR and gel electrophoresis were used to confirm the zygosity of PDGFRαEGFP mice. Histological examination and fluorescence imaging were used to identify PDGFRα expression within testicular tissue. Immunohistochemical analysis assessed the co-expression of PDGFRα with c-Kit, ANO-1, and TASK-1 in testicular cells. Results: Genotyping confirmed the heterozygous status of the mice, which is crucial for studies due to the embryonic lethal phenotype observed in homozygotes. Histological and fluorescence imaging revealed that PDGFRα+ cells were primarily located in the interstitial spaces of the testis, specifically within Leydig cells and peritubular myoid cells (PMCs). Immunohistochemical results showed PDGFRα co-localization with c-Kit and ANO-1 in Leydig cells and a complete co-localization with TASK-1 in both Leydig cells and PMCs. Conclusions: The findings demonstrate specific expression of PDGFRα in Leydig cells and PMCs in adult testicular tissue. The co-expression of PDGFRα with c-Kit, ANO-1, and TASK-1 suggests complex regulatory mechanisms, possibly influencing testicular function and broader physiological processes.

본 연구는 소리곤충을 활용한 동물매개치료 프로그램이 노인의 우울에 어떠한 영향을 미치는지 살펴보고자 하였다. 연구대상은 I시에 위치한 I치매안심센터에서 추천을 받은 우울 척도 검사에서 5점 이상을 받은 노인 20명이며, 실험집단과 통제집단 각 10명을 선정하였다. 프로그램은 2023년 6월부터 8월까지 주 1회, 회기당 50분 씩 총 12회기를 실시하였다. 효과 검증을 위해 SPSS v.26을 활용하여 집단 간 동질성 검증(Mann-Whitney U test)을 하여 동질성이 입증이 된 후 각 집단의 사전과 사후에 노인 우울 척도 측정을 실시하고 비모수 윌콕슨 부호 순위 검정(Wilcoxon signed-rank test)으로 분석하였다. 그 결과, 실험집단의 우울 전체의 사전・사후에 유의미한 차이 가 나타났다(Z=-3.53, p＜.05). 그러나 통제집단의 우울 전체의 사전・사후에는 유의미한 차이가 나타나지 않았 다(Z=-1.06, p>.05). 따라서 본 연구는 소리곤충을 활용한 동물매개치료 프로그램이 노인의 우울에 긍정적인 영향 을 준 것으로 확인이 되었다. 이번 연구결과는 소리곤충을 활용한 정서 및 심리 치료에 대한 과학적 근거를 제시하 여 관련 분야 활성화에 기여할 수 있을 것으로 기대된다.